✨ Fisheries and Health Notices
396 NEW ZEALAND GAZETTE No. 11
Quota Management Area 8
| Bycatch Species | Method(s) | Target Species | ||
|---|---|---|---|---|
| Gur 8 | Spo 8 | War 8 | ||
| BT | SN | SN | ||
| Rco 2 | 0.27 | - | 0.15 | |
| Sch 8 | - | 0.67 | 0.75 | |
| Sna 8 | 3.97 | - | - | |
| Spo 8 | - | - | 1.13 |
Quota Management Area 9
| Bycatch Species | Method(s) | Target Species | |||
|---|---|---|---|---|---|
| Hpb 1 | Sna 8 | Sna 8 | Spo 1 | ||
| BLL, DL, HL | BLL | BPT, BT | SN | ||
| Gur 1 | - | 0.25 | 0.25 | 0.25 | |
| Jdo 1 | - | - | 0.83 | - | |
| Spo 1 | - | - | 0.69 | - | |
| Sch 1 | 0.34 | 0.33 | 0.33 | 0.48 | |
| Tar 1 | - | - | 0.75 | - | |
| Tre 7 | - | 0.28 | 0.28 | 0.40 |
Dated this 1st day of February 1996.
A. J. HORE, Policy Manager North.
- S.R. 1986/267
† S.R. 1990/214
go886
Health
Medicines Act 1981
Corrigendum
Consent to the Distribution of New Medicines
In the notice published in the New Zealand Gazette, 14 December 1995, No. 147, page 3615, notice No. 8284, for the word “Halperidol” in the twenty-eighth line, replace with the word “Haloperidol” and for the word “desflurane” in the thirty-eighth line, replace with the word “desflurane”.
Dated this 31st day of January 1996.
HUGH BABER, Assistant General Manager, Health Regulation & Protection, pursuant to delegation given by the Minister of Health on 18 January 1996.
go785
Consent to the Distribution of Changed Medicines
Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Acetylsalicylic acid 100 mg | Tablet | Reckitt & Colman Pharmaceuticals Limited, West Ryde, New South Wales, Australia | Cardiprin |
| Famciclovir 125 mg, 250 mg | Tablets | SmithKline Beecham Pharmaceuticals, Magpie, Wood, Manor Royal, Crawley, Sussex, England | Famvir |
| Morphine sulphate 20 mg, 50 mg, 100 mg | Capsule, sustained release | Faulding Pharmaceuticals, Salisbury, South Australia, Australia | Kapanol |
| Note: Not to be marketed as substitutable for any other morphine sulphate product as if the two (2) products were bioequivalent. | |||
| Amorolfine hydrochloride 5% in 2.5 mL, 5 mL | Lacquer, nail | Produits Roche SA, Fontenay sous Bois, France | Loceryl Nail Lacquer |
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1996, No 11
NZLII —
NZ Gazette 1996, No 11
✨ LLM interpretation of page content
🌾
Fisheries (Bycatch Trade-off) Notice (No. 1) 1996
(continued from previous page)
🌾 Primary Industries & Resources1 February 1996
Fisheries, Bycatch Trade-off, Quota Management Area
- A. J. Hore, Policy Manager North
🏥 Corrigendum to Consent to the Distribution of New Medicines
🏥 Health & Social Welfare31 January 1996
Medicines Act, Corrigendum, Health Regulation
- Hugh Baber, Assistant General Manager, Health Regulation & Protection
🏥 Consent to the Distribution of Changed Medicines
🏥 Health & Social Welfare31 January 1996
Medicines Act, Changed Medicines, Health Regulation
- Hugh Baber, Assistant General Manager, Health Regulation & Protection